for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-GSK And Vir Biotechnology Announce Joint Procurement Deal With European Commission For Sotrovimab

July 28 (Reuters) - GlaxoSmithKline PLC:

* GSK AND VIR BIOTECHNOLOGY ANNOUNCE JOINT PROCUREMENT AGREEMENT WITH EUROPEAN COMMISSION FOR COVID-19 TREATMENT, SOTROVIMAB

* GSK - AGREEMENT WITH THE EUROPEAN COMMISSION TO SUPPLY UP TO 220,000 DOSES OF SOTROVIMAB

* GSK - CONTINUING TO EVALUATE ABILITY OF SOTROVIMAB TO MAINTAIN ACTIVITY AGAINST NEW AND EMERGING VARIANTS THROUGH IN VITRO STUDIES

* GSK - CONTINUING TO EVALUATE ABILITY OF SOTROVIMAB TO MAINTAIN ACTIVITY AGAINST NEW AND EMERGING VARIANTS THROUGH IN VITRO STUDIES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up